AMT-116 in Patients With Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Dallas +1 more location
Sponsor: Multitude Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT05725291·Phase 1·Recruiting·Listed Feb 2023
Solid tumor Clinical Trials in Dallas, TX
As of August 2026, 59 paid clinical trials are recruiting for Solid tumor in Dallas, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Dallas
Filter results
Filter results
59 clinical trials for Solid tumor
·Clear filters· Email me when a new solid tumor trial opens in Dallas, TX.
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
for Solid Tumor, Adult
Sites in Dallas, Houston +2 more locations
Sponsor: Bio-Path Holdings, Inc.
Sex: All·Age: 18+
Code: NCT04196257·Phase 1·Recruiting·Listed Dec 2019
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
for Solid Tumors
Sites in Dallas +3 more locations
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All·Age: 18+
Code: NCT05490472·Phase 1, Phase 2·Recruiting·Listed Aug 2022
A Study of LM-24C5 For Advanced Solid Tumors
for Advanced Solid Tumor
Sites in Dallas +5 more locations
Sponsor: LaNova Medicines Limited
Sex: All·Age: 18+
Code: NCT06187402·Phase 1, Phase 2·Recruiting·Listed Jan 2024
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
for Advanced Solid Tumor
Sites in Dallas, San Antonio +3 more locations
Sponsor: 1ST Biotherapeutics, Inc.
Sex: All·Age: 18+
Code: NCT05761223·Phase 1, Phase 2·Recruiting·Listed Mar 2023
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
for Solid Tumor
1 location in Dallas
Sponsor: Abbisko Therapeutics Co, Ltd
Sex: All·Age: 18+
Code: NCT05244551·Phase 1·Recruiting·Listed Feb 2022
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for Advanced Malignant Solid Neoplasm
Sites in Dallas, Temple +429 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: All ages
Code: NCT05564377·Phase 2·Recruiting·Listed Oct 2022
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
for Hematopoietic and Lymphatic System Neoplasm
Sites in Dallas, Fort Worth +189 more locations
Sponsor: Children's Oncology Group
Sex: Female·Age: Up to 39
Code: NCT06513962·Phase 3·Recruiting·Listed Jul 2024
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
for Malignant Female Reproductive System Neoplasm
Sites in Dallas, Temple +176 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06126276·Phase 2·Recruiting·Listed Nov 2023
Project: Every Child for Younger Patients With Cancer
for Adrenal Gland Pheochromocytoma
Sites in Dallas, Fort Worth +225 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 25
Code: NCT02402244·Recruiting·Listed Mar 2015
Personalized Radiotherapy for Individualized Treatment Strategies and Monitoring (PRISM)
for Small Cell Lung Cancer Extensive Stage
1 location in Dallas
Sponsor: University of Texas Southwestern Medical Center
Sex: All·Age: 18+
Code: NCT07139990·Phase 1·Recruiting·Listed Aug 2025
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
for Autoimmune Disease
Drug: Nivolumab
Sites in Dallas, Richardson +39 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT03816345·Phase 1·Recruiting·Listed Jan 2019
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
for Solid Tumor
Drug: Atezolizumab
Sites in Dallas, Houston +5 more locations
Sponsor: University of Texas Southwestern Medical Center
Sex: All·Age: 6 Months - 30
Code: NCT04796012·Phase 1, Phase 2·Recruiting·Listed Mar 2021
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for Hematopoietic and Lymphoid Cell Neoplasm
Sites in Dallas, Houston +26 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: 2 - 18
Code: NCT05711667·Phase 3·Recruiting·Listed Feb 2023
Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant
for Hematopoietic and Lymphoid Cell Neoplasm
Sites in Dallas & Houston
Sponsor: M.D. Anderson Cancer Center
Sex: All·Age: 6 - 29
Code: NCT04678427·Recruiting·Listed Dec 2020
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for Hematopoietic and Lymphatic System Neoplasm
Sites in Dallas, Fort Worth +74 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: 15 - 20
Code: NCT06410209·Phase 2·Recruiting·Listed May 2024
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
for Non-small Cell Lung Cancer
Sites in Dallas, Houston +16 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT06218914·Phase 1·Recruiting·Listed Jan 2024
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for Solid Tumors
Sites in Dallas +16 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06431594·Phase 1·Recruiting·Listed May 2024
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for Solid Tumor
Sites in Dallas +16 more locations
Sponsor: Biohaven Therapeutics Ltd.
Sex: All·Age: 18+
Code: NCT06384807·Phase 1, Phase 2·Recruiting·Listed Apr 2024